NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

Also called NCT06511505

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06511505
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06511505. Randomized; no masking; primary purpose screening. Start 2024-09-16 (actual); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
Acronym
NOTABLE
Condition
Cardiovascular Diseases
Condition
Arrhythmia
Condition
Valvular Disease
Intervention (Device)
Risk-Based Assessment for Cardiac Dysfunction
Lead sponsor
Northwestern University (class: other)
Collaborator
Tempus AI (class: industry)

Record details

Record id
cardio:ct-nct06511505
Content hash
e14e7649b5ca3e54283b03ac81f3d8466db55690fb79af9365d69133d8dd8004